1. Home
  2. NXPLW vs TECH Comparison

NXPLW vs TECH Comparison

Compare NXPLW & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPLW
  • TECH
  • Stock Information
  • Founded
  • NXPLW N/A
  • TECH 1976
  • Country
  • NXPLW United States
  • TECH United States
  • Employees
  • NXPLW 166
  • TECH N/A
  • Industry
  • NXPLW Telecommunications Equipment
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NXPLW Telecommunications
  • TECH Health Care
  • Exchange
  • NXPLW Nasdaq
  • TECH Nasdaq
  • Market Cap
  • NXPLW N/A
  • TECH 8.0B
  • IPO Year
  • NXPLW N/A
  • TECH 1989
  • Fundamental
  • Price
  • NXPLW N/A
  • TECH $48.10
  • Analyst Decision
  • NXPLW
  • TECH Buy
  • Analyst Count
  • NXPLW 0
  • TECH 9
  • Target Price
  • NXPLW N/A
  • TECH $81.25
  • AVG Volume (30 Days)
  • NXPLW 6.4K
  • TECH 2.2M
  • Earning Date
  • NXPLW 03-31-2025
  • TECH 05-07-2025
  • Dividend Yield
  • NXPLW N/A
  • TECH 0.63%
  • EPS Growth
  • NXPLW N/A
  • TECH N/A
  • EPS
  • NXPLW N/A
  • TECH 0.98
  • Revenue
  • NXPLW $66,482,000.00
  • TECH $1,196,016,000.00
  • Revenue This Year
  • NXPLW N/A
  • TECH $8.19
  • Revenue Next Year
  • NXPLW N/A
  • TECH $8.85
  • P/E Ratio
  • NXPLW N/A
  • TECH $49.09
  • Revenue Growth
  • NXPLW 179.89
  • TECH 4.46
  • 52 Week Low
  • NXPLW $0.25
  • TECH $46.44
  • 52 Week High
  • NXPLW $0.26
  • TECH $85.57
  • Technical
  • Relative Strength Index (RSI)
  • NXPLW N/A
  • TECH 33.97
  • Support Level
  • NXPLW N/A
  • TECH $46.44
  • Resistance Level
  • NXPLW N/A
  • TECH $53.00
  • Average True Range (ATR)
  • NXPLW 0.00
  • TECH 3.30
  • MACD
  • NXPLW 0.00
  • TECH -0.27
  • Stochastic Oscillator
  • NXPLW 0.00
  • TECH 13.00

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: